Physician profile
Daniel Lee
NPI 1295823755
$3,954.56
in general payments reported to CMS, 2019-2025
18 companies · $743 in 2025
The $743 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $648 · 2020: $272 · 2021: $213 · 2022: $461 · 2023: $650 · 2024: $968 · 2025: $743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,343 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,342.75 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,247.84 | 2019-2025 | Hydrus Microstent, Rocklatan, Centurion |
| Abbvie INC. | $768.54 | 2023-2025 | |
| Glaukos Corporation | $690.24 | 2019-2024 | Idose |
| Aerie Pharmaceuticals, INC. | $278.57 | 2019-2021 | |
| Amgen INC. | $168.85 | 2024-2025 | Tepezza |
| Novartis Pharmaceuticals Corporation | $140.70 | 2019 | |
| Abbott Laboratories | $121.83 | 2019 | |
| Allergan, INC. | $111.90 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $90.10 | 2023-2024 | Vyzulta, Miebo |
| Sun Pharmaceutical Industries INC. | $84.01 | 2022-2025 | |
| Kala Pharmaceuticals, INC. | $54.75 | 2019 | |
| Mallinckrodt Hospital Products INC. | $54.33 | 2025 | Acthar |
| Biotissue Holdings INC. | $38.75 | 2022-2023 | |
| Horizon Therapeutics Plc | $34.35 | 2023 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $19.28 | 2024 | Xdemvy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $19.19 | 2022 | |
| Dompe US, INC. | $17.54 | 2025 | Oxervate |
| Baxter Healthcare | $13.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.